Relation between serum vitamin B 12 level and duration of treatment with carbamazepine in epilepsy patients
Mohammad Tariqul Islam, Khair M. Sobhan, Mahjabin Rahman Shawly and 3 more
Bangabandhu Sheikh Mujib Medical University Journal · 2016
doi:10.3329/bsmmuj.v9i4.30371 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
Vitamin B12 levels in the serum of 58 epileptic patients receiving only carbamazepine for at least 6 months were measured. Same number of epilepsy patients with no history of taking antiepileptic medicine were taken as control. The mean level of vitamin B12 in carbamazepine-treated epileptic patients was 265.5 pg/mL whereas it was 478.3 pg/mL in control. Increased duration of treatment of carbamazepine in epilepsy caused significantly decreased level of serum vitamin B12 (Pearson correlation coefficient, r = -0.9, p<0.0001). In conclusion, serum vitamin B12 level significantly decreased in relation to duration of carbamazepine treatment in epileptic patients.
Abstract licence: CC BY
References15
15 more references, whose wording the paper’s licence keeps private.
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.